Sunitinib Alone or After Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Is There Still a Role for Cytoreductive Nephrectomy?-Reference-Cited by-同舟云学术

Sunitinib Alone or After Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Is There Still a Role for Cytoreductive Nephrectomy?

Published:2021-10 Issue:4 Volume:80 Page:417-424
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Méjean Arnaud^ORCID,Ravaud Alain,Thezenas Simon,Chevreau Christine,Bensalah Karim,Geoffrois Lionnel,Thiery-Vuillemin Antoine,Cormier Luc,Lang Hervé,Guy Laurent,Gravis Gwenaelle,Rolland Frederic,Linassier Claude,Lechevallier Eric,Oudard Stephane,Laguerre Brigitte,Gross-Goupil Marine,Bernhard Jean Christophe,Colas Sandra,Albiges Laurence,Lebret Thierry,Treluyer Jean-Marc,Timsit Marc-Olivier,Escudier Bernard

Publisher

Elsevier BV

Subject

Urology

Reference13 articles.

1. National Comprehensive Cancer Network. National Comprehensive Cancer Network clinical practice guidelines in oncology: kidney cancer. https://www.nccn.org/professionals/physician_gls/pdf/kidney.pdf.

2. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer;Flanigan;N Engl J Med,2001

3. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial;Mickisch;Lancet,2001

4. Sunitinib alone or after nephrectomy in metastatic renal-cell carcinoma;Mejean;N Engl J Med,2018

5. Updated European Association of Urology guidelines for cytoreductive nephrectomy in patients with synchronous metastatic clear-cell renal cell carcinoma;Bex;Eur Urol,2018

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Cytoreductive Nephrectomy in Metastatic Clear Cell Renal cell Carcinoma in the Era of immunotherapy: An Analysis of the National Cancer Database;Clinical Genitourinary Cancer;2024-12

2. Conséquences chirurgicales et anatomopathologiques de l’immunothérapie préopératoire en onco-urologie;Bulletin du Cancer;2024-09

3. Targeting the Adenosine A2A Receptor as a Novel Therapeutic Approach for Renal Cell Carcinoma: Mechanisms and Clinical Trial Review;Pharmaceutics;2024-08-27

4. Contemporary Management of Renal Cell Carcinoma: A Review for General Practitioners in Oncology;Current Oncology;2024-08-22

5. Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis Database;Current Oncology;2024-08-18